The FDA has authorized multiple COVID treatments, but they remain limited for the foreseeable future due to the belief that...
Read moreAbortion is defined as a right to privacy in Roe v. Wade. The ruling protects a fundamental right but it...
Read moreThe courts recently ruled vaccine mandates as unconstitutional and against public interests. But by emphasizing economic interests over public health...
Read moreThe Supreme Court has agreed to clarify the question of good faith as it pertains to physician prescribing behavior. In...
Read moreProsecutors often use patient data to investigate physicians. But patient data is biased, lacking the robustness required of evidence. And...
Read moreDr. Zena Crenshaw-Logal has taken what she learned as an advocate for judicial reform to launch America United International.
Read moreThe DEA recently issued a public health alert, warning of counterfeit pills. A seemingly odd alert given the DEA's restrictions...
Read moreThe CDC might reverse course again, this time on mixing vaccine formularies. We review the science and politics underlying the...
Read moreThe FDA approved a booster dose for COVID-19 vaccines. A sensible decision, but we are concerned at how they derived...
Read moreThe United States has a long history of restricting abortions, using the pretense of medicine to enact laws that moralize...
Read moreHealthcare laws restrict specific aspects of healthcare behavior. But in restricting, they reduce complex behavior into simplified restrictions.
Read moreIsrael has become an international leader in COVID-19 research. But we should question whether we can apply Israeli data into...
Read moreClinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy